Bacteroides fragilis enterotoxin upregulates lipocalin-2 expression in intestinal epithelial cells

Laboratory Investigation

Volumn 93, Issue 4, 2013, Pages 384-396

  Yoo, Do Young ^a   Ko, Su Hyuk ^a   Jung, Jireh ^a   Kim, Young Jeon ^b   Kim, Joo Sung ^c   Kim, Jung Mogg ^a  

^a Hanyang University College of Medicine   (South Korea)

^b Joongbu University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

AP 1; Bacteroides fragilis enterotoxin; intestinal epithelial cells; mitogen activated protein kinase

Indexed keywords

BETA DEFENSIN 2; FRAGILYSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SYNTHESIS; UPREGULATION;

ACUTE-PHASE PROTEINS; BACTERIAL TOXINS; EPITHELIAL CELLS; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; LIPOCALINS; MAP KINASE SIGNALING SYSTEM; METALLOENDOPEPTIDASES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 84875749804     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.1     Document Type: Article

References (52)

1. Prindiville TP, Sheikh RA, Cohen SH, et al. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis 2000;6:171-174.
2. Sears CL, Islam S, Saha A, et al. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis 2008;47:797-803.
3. Toprak NU, Yagci A, Gulluoglu BM, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006;12:782-786.
4. Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009;15:1016-1022.
5. Sears CL Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev 2009;22:349-369.
6. Cash HL, Whitham CV, Behrendt CL, et al. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006;313: 1126-1130.
7. Howell SJ, Wilk D, Yadav SP, et al. Antimicrobial polypeptides of the human colonic epithelium. Peptides 2003;24:1763-1770.
8. Nuding S, Zabel LT, Enders C, et al. Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3. Microbes Infect 2009;11:384-393.
9. Tollin M, Bergman P, Svenberg T, et al. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 2003;24:523-530.
10. Yoon YM, Lee JY, Yoo D, et al. Bacteroides fragilis enterotoxin induces human beta-defensin-2 expression in intestinal epithelial cells via a mitogen-activated protein kinase/IkappaB kinase/NF-kappaB-dependent pathway. Infect Immun 2010;78:2024-2033.
11. Sears CL. The toxins of Bacteroides fragilis. Toxicon 2001;39:1737-1746.
12. Sears CL, Myers LL, Lazenby A, et al. Enterotoxigenic Bacteroides fragilis. Clin Infect Dis 1995;20(Suppl 2):S142-S148.
13. Nakano V, Gomes DA, Arantes RM, et al. Evaluation of the pathogenicity of the Bacteroides fragilis toxin gene subtypes in gnotobiotic mice. Curr Microbiol 2006;53:113-117.
14. Rhee KJ, Wu S, Wu X, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun 2009;77:1708-1718.
15. Rabizadeh S, Rhee KJ, Wu S, et al. Enterotoxigenic Bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis 2007;13:1475-1483.
16. Miethke M, Skerra A. Neutrophil gelatinase-associated lipocalin expresses antimicrobial activity by interfering with L-norepinephrine-mediated bacterial iron acquisition. Antimicrob Agents Chemother 2010;54:1580-1589.
17. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004;432:917-921.
18. Chan YR, Liu JS, Pociask DA, et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 2009;182: 4947-4956.
19. Fischbach MA, Lin H, Zhou L, et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA 2006;103:16502-16507.
20. Li C, Chan YR. Lipocalin 2 regulation and its complex role in inflammation and cancer. Cytokine 2011;56:435-441.
21. Cowland JB, S0rensen OE, Sehested M, et al. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003;171:6630-6639.
22. Gwira JA, Wei F, Ishibe S, et al. Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 2005;280:7875-7882.
23. Hanai J, Mammoto T, Seth P, et al. Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J Biol Chem 2005;280: 13641-13647.
24. Matsuo S, Yamazaki S, Takeshige K, et al. Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation. Biochem J 2007;405:605-615.
25. Kim JM, Lee DH, Kim JS, et al. 5, 7-dihydroxy-3, 4, 6-trimethoxyflavone inhibits the inflammatory effects induced by Bacteroides fragilis enterotoxin via dissociating the complex of heat shock protein 90 and IkappaB alpha and IkappaB kinase-gamma in intestinal epithelial cell culture. Clin Exp Immunol 2009;155:541-551.
26. Kim JM, Jung HY, Lee JY, et al. Mitogen-activated protein kinase and activator protein-1 dependent signals are essential for Bacteroides fragilis enterotoxin-induced enteritis. Eur J Immunol 2005;35: 2648-2657.
27. Kim JM, Lee JY, Kim YJ. Inhibition of apoptosis in Bacteroides fragilis enterotoxin-stimulated intestinal epithelial cells through the induction of c-IAP-2. Eur J Immunol 2008;38:2190-2199.
28. Kim JM, Lee JY, Yoon YM, et al. Bacteroides fragilis enterotoxin induces cyclooxygenase-2 and fluid secretion in intestinal epithelial cells through NF-kappaB activation. Eur J Immunol 2006;36:2446-2456.
29. Kim JM, Cho SJ, Oh YK, et al. Nuclear factor-kappa B activation pathway in intestinal epithelial cells is a major regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin. Clin Exp Immunol 2002;130:59-66.
30. Kim JM, Oh YK, Kim YJ, et al. Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-kappa B plays a major role in the regulation of IL-8 expression. Clin Exp Immunol 2001;123:421-427.
31. Wu S, Powell J, Mathioudakis N, et al. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway. Infect Immun 2004;72:5832-5839.
32. Huang C, Ma WY, Dawson MI, et al. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci USA 1997;94:5826-5830.
33. Roh HC, Yoo DY, Ko SH, et al. Bacteroides fragilis enterotoxin upregulates intercellular adhesion molecule-1 in endothelial cells via an aldose reductase-, MAPK-, and NF-kB-dependent pathway, leading to monocyte adhesion to endothelial cells. J Immunol 2011;187:1931-1941.
34. Hurley BP, Sin A, McCormick BA. Adhesion molecules involved in hepoxilin A3-mediated neutrophil transepithelial migration. Clin Exp Immunol 2008;151:297-305.
35. Kim JM, Kim JS, Jung HC, et al. Helicobacter pylori infection activates NF-kappaB signaling pathway to induce iNOS and protect human gastric epithelial cells from apoptosis. Am J Physiol Gastrointest Liver Physiol 2003;285:G1171-G1180.
36. Lee JY, Park HR, Oh YK, et al. Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A. J Mol Med 2007;85:1393-1404.
37. Park H, Kim NI, Kim JM, et al. Expression of eotaxin in gastric epithelial cells stimulated with Helicobacter pylori vacuolating cytotoxin. J Bacteriol Virol 2006;36:11-20.
38. Wehkamp K, Schwichtenberg L, Schröder JM, et al. Pseudomonas aeruginosa-and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol 2006;126:121-127.
39. Elewaut D, DiDonato JA, Kim JM, et al. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J Immunol 1999;163:1457-1466.
40. Brown PH, Alani R, Preis LH, et al. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 1993;8:877-886.
41. Kim JM, Kim JS, Kim YJ, et al. Conjugated linoleic acids produced by Lactobacillus dissociates IKK-gamma and Hsp90 complex in Helicobacter pylori-infected gastric epithelial cells. Lab Invest 2008;88: 541-552.
42. Lee JY, Kim H, Cha MY, et al. Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-kappaB signaling pathway. J Mol Med 2009; 87:169-180.
43. Raffatellu M, George MD, Akiyama Y, et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 2009;5:476-486.
44. Yuk JM, Jo EK. Toll-like receptors and innate immunity. J Bacteriol Virol 2011;41:225-235.
45. Lopez-Bergami P, Lau E, Ronai Z. Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 2010;10:65-76.
46. Backert S, Naumann M. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 2010;18: 479-486.
47. Manzoor Z, Koh YS. Mitogen-activated protein kinases in inflammation. J Bacteriol Virol 2012;42:189-195.
48. Berger T, Togawa A, Duncan GS, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 2006;103:1834-1839.
49. Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002;10:1033-1043.
50. Otto BR, Sparrius M, Verweij-van Vught AM, et al. Iron-regulated outer membrane protein of Bacteroides fragilis involved in heme uptake. Infect Immun 1990;58:3954-3958.
51. Otto BR, Verweij-van Vught AM, MacLaren DM. Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit Rev Microbiol 1992;18:217-233.
52. Sijbrandi R, Den Blaauwen T, Tame JR, et al. Characterization of an iron-regulated alpha-enolase of Bacteroides fragilis. Microbes Infect 2005;7:9-18.